137 related articles for article (PubMed ID: 9921923)
1. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotype, histopathology and clinical stage: their predictive value in the prognosis of non-Hodgkin's lymphomas.
Mtasiwa DM; Imamura N; Inada T; Takimoto Y; Okada K; Nanba K; Asaoku H; Kuramoto A
Hiroshima J Med Sci; 1990 Dec; 39(4):95-102. PubMed ID: 2086567
[TBL] [Abstract][Full Text] [Related]
4. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.
Stelitano C; Baldini L; Pieresca C; Callea V; Angrilli F; Clò V; Partesotti G; Merli F; Cavanna L; Morabito F; Federico M; Brugiatelli M; Silingardi V
Haematologica; 2000 Feb; 85(2):154-9. PubMed ID: 10681722
[TBL] [Abstract][Full Text] [Related]
5. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
[TBL] [Abstract][Full Text] [Related]
6. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas.
Czader M; Mazur J; Pettersson M; Liliemark J; Strömberg M; Christensson B; Tribukait B; Auer G; Ost A; Porwit A
Cancer; 1996 Mar; 77(6):1180-8. PubMed ID: 8635141
[TBL] [Abstract][Full Text] [Related]
9. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
[TBL] [Abstract][Full Text] [Related]
10. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma.
Iyer VK; Raina V; Dawar R
Indian J Cancer; 2000 Dec; 37(4):140-7. PubMed ID: 12018565
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and grading of non-Hodgkin's lymphomas on fine needle aspiration cytology.
Mathur S; Dawar R; Verma K
Indian J Pathol Microbiol; 2007 Jan; 50(1):46-50. PubMed ID: 17474258
[TBL] [Abstract][Full Text] [Related]
12. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
13. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
14. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
[TBL] [Abstract][Full Text] [Related]
16. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
Nizze H; Bühring U
Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239
[TBL] [Abstract][Full Text] [Related]
17. Morphological and clinical significance of cell kinetics in non-Hodgkin's lymphomas.
Del Bino G; Silvestrini R; Costa A; Veneroni S; Giardini R
Basic Appl Histochem; 1986; 30(2):197-202. PubMed ID: 3741316
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
[TBL] [Abstract][Full Text] [Related]
19. [Validity of the International Prognostic Index in non-Hodgkin's lymphomas of varying grades of malignancy].
Bettini R; Caronni F; Maino C; Marzetta K; Sala D; Saccà V; Gorini M
Recenti Prog Med; 2003 Nov; 94(11):494-500. PubMed ID: 14679917
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA
Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
